Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
NCT02632552 · View on ClinicalTrials.gov ↗
Study Summary
Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.
Interventions
- BEHAVIORAL Technology-assisted care transition intervention
- BEHAVIORAL Active attention control
Study Locations (5)
Massachusetts
- VA Bedford HealthCare System, Bedford, MA — Bedford
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA — Boston
California
- VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL — Hines
Iowa
- Iowa City VA Health Care System, Iowa City, IA — Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02632552
The ClinicalTrials.gov registry entry for NCT02632552 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,863 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions — of which Technology-assisted care transition intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02632552 reports 5 study locations spanning 4 distinct geographic areas — top geographies include Massachusetts, California, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02632552 about?
NCT02632552 is a clinical study titled "A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD". Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for th...
What is the current status of trial NCT02632552?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-05-01. Estimated completion is 2021-08-31.
What conditions does trial NCT02632552 study?
This clinical trial studies the following conditions: COPD, CHF. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02632552?
The interventions under investigation include: Technology-assisted care transition intervention (BEHAVIORAL), Active attention control (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02632552?
This trial is sponsored by VA Office of Research and Development, which has 1,863 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02632552 being conducted?
This trial has 5 study locations across California, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.